CDH1 mutation screen in a BRCA1/2-negative familial breast-/ovarian cancer cohort.
Frederik A StuebsSimone HeidemannAlmuth CaliebeChristoph MundhenkeNorbert ArnoldPublished in: Archives of gynecology and obstetrics (2017)
Although none of the probands studied carried a clearly pathogenic CDH1 mutation, CDH1 could be considered a potential breast cancer gene, esp. for ILC worth including it in the NGS (next generation sequencing) HBOC panel.